134 related articles for article (PubMed ID: 23838408)
1. Population-based, risk-stratified genetic testing for ovarian cancer risk: a focus group study.
Meisel SF; Side L; Fraser L; Gessler S; Wardle J; Lanceley A
Public Health Genomics; 2013; 16(4):184-91. PubMed ID: 23838408
[TBL] [Abstract][Full Text] [Related]
2. Attitudes towards a programme of risk assessment and stratified management for ovarian cancer: a focus group study of UK South Asians' perspectives.
Hann KEJ; Ali N; Gessler S; Fraser LSM; Side L; Waller J; Sanderson SC; Lanceley A;
BMJ Open; 2018 Jul; 8(7):e021782. PubMed ID: 30021754
[TBL] [Abstract][Full Text] [Related]
3. Genetic testing and personalized ovarian cancer screening: a survey of public attitudes.
Meisel SF; Rahman B; Side L; Fraser L; Gessler S; Lanceley A; Wardle J;
BMC Womens Health; 2016 Jul; 16():46. PubMed ID: 27460568
[TBL] [Abstract][Full Text] [Related]
4. Population-based genetic risk prediction and stratification for ovarian cancer: views from women at high risk.
Rahman B; Meisel SF; Fraser L; Side L; Gessler S; Wardle J; Lanceley A
Fam Cancer; 2015 Mar; 14(1):135-44. PubMed ID: 25391615
[TBL] [Abstract][Full Text] [Related]
5. Health care professionals' attitudes towards population-based genetic testing and risk-stratification for ovarian cancer: a cross-sectional survey.
Hann KEJ; Fraser L; Side L; Gessler S; Waller J; Sanderson SC; Freeman M; Jacobs I; Lanceley A;
BMC Womens Health; 2017 Dec; 17(1):132. PubMed ID: 29246147
[TBL] [Abstract][Full Text] [Related]
6. Awareness of ovarian cancer risk factors, beliefs and attitudes towards screening: baseline survey of 21,715 women participating in the UK Collaborative Trial of Ovarian Cancer Screening.
Fallowfield L; Fleissig A; Barrett J; Menon U; Jacobs I; Kilkerr J; Farewell V;
Br J Cancer; 2010 Aug; 103(4):454-61. PubMed ID: 20648018
[TBL] [Abstract][Full Text] [Related]
7. Population-based genetic testing for Women's cancer prevention.
Evans O; Gaba F; Manchanda R
Best Pract Res Clin Obstet Gynaecol; 2020 May; 65():139-153. PubMed ID: 32245629
[TBL] [Abstract][Full Text] [Related]
8. Women's perception, attitudes, and intended behavior towards predictive epigenetic risk testing for female cancers in 5 European countries: a cross-sectional online survey.
Wegwarth O; Pashayan N; Widschwendter M; Rebitschek FG
BMC Public Health; 2019 May; 19(1):667. PubMed ID: 31146730
[TBL] [Abstract][Full Text] [Related]
9. A qualitative study of women's experiences of familial ovarian cancer screening.
Lifford KJ; Clements A; Fraser L; Lancastle D; Brain K;
Psychooncology; 2013 Nov; 22(11):2576-84. PubMed ID: 23801640
[TBL] [Abstract][Full Text] [Related]
10. Results of annual screening in phase I of the United Kingdom familial ovarian cancer screening study highlight the need for strict adherence to screening schedule.
Rosenthal AN; Fraser L; Manchanda R; Badman P; Philpott S; Mozersky J; Hadwin R; Cafferty FH; Benjamin E; Singh N; Evans DG; Eccles DM; Skates SJ; Mackay J; Menon U; Jacobs IJ
J Clin Oncol; 2013 Jan; 31(1):49-57. PubMed ID: 23213100
[TBL] [Abstract][Full Text] [Related]
11. [Risk-adapted surveillance: focus on familial breast and ovarian cancer].
Rhiem K; Schmutzler RK
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Mar; 57(3):307-11. PubMed ID: 24562705
[TBL] [Abstract][Full Text] [Related]
12. National Estimates of Genetic Testing in Women With a History of Breast or Ovarian Cancer.
Childers CP; Childers KK; Maggard-Gibbons M; Macinko J
J Clin Oncol; 2017 Dec; 35(34):3800-3806. PubMed ID: 28820644
[TBL] [Abstract][Full Text] [Related]
13. Receipt of a false positive test result during routine screening for ovarian cancer: a teachable moment?
Floyd A; Steffens RF; Pavlik E; Andrykowski MA
J Clin Psychol Med Settings; 2011 Mar; 18(1):70-7. PubMed ID: 21373852
[TBL] [Abstract][Full Text] [Related]
14. [Clinical and molecular diagnosis of inherited breast-ovarian cancer].
Chompret A
J Gynecol Obstet Biol Reprod (Paris); 2003 Apr; 32(2):101-19. PubMed ID: 12717301
[TBL] [Abstract][Full Text] [Related]
15. Germline BRCA1/2 testing practices in ovarian cancer: Current state and opportunities for new directions.
Lheureux S; Karakasis K; Harter P; Scott C; Bacon M; Bryce J; Le Fur N; Pujade-Lauraine E; Oza AM
Gynecol Oncol; 2016 Jan; 140(1):90-4. PubMed ID: 26475959
[TBL] [Abstract][Full Text] [Related]
16. Genetic counseling, testing, and screening for breast and ovarian cancer: practical and social considerations.
Khabele D; Runowicz CD
Curr Womens Health Rep; 2002 Jun; 2(3):163-9. PubMed ID: 12099190
[TBL] [Abstract][Full Text] [Related]
17. The histomorphology of Lynch syndrome-associated ovarian carcinomas: toward a subtype-specific screening strategy.
Chui MH; Ryan P; Radigan J; Ferguson SE; Pollett A; Aronson M; Semotiuk K; Holter S; Sy K; Kwon JS; Soma A; Singh N; Gallinger S; Shaw P; Arseneau J; Foulkes WD; Gilks CB; Clarke BA
Am J Surg Pathol; 2014 Sep; 38(9):1173-81. PubMed ID: 25025451
[TBL] [Abstract][Full Text] [Related]
18. Selecting Patients with Ovarian Cancer for Germline BRCA Mutation Testing: Findings from Guidelines and a Systematic Literature Review.
Eccles DM; Balmaña J; Clune J; Ehlken B; Gohlke A; Hirst C; Potter D; Schroeder C; Tyczynski JE; Gomez Garcia EB
Adv Ther; 2016 Feb; 33(2):129-50. PubMed ID: 26809252
[TBL] [Abstract][Full Text] [Related]
19. Population-based Genetic Testing for Precision Prevention.
Evans O; Manchanda R
Cancer Prev Res (Phila); 2020 Aug; 13(8):643-648. PubMed ID: 32409595
[TBL] [Abstract][Full Text] [Related]
20. Impact of Implementing B-RST
Wernke K; Bellcross C; Gabram S; Ali N; Stanislaw C
Clin Breast Cancer; 2019 Aug; 19(4):e547-e555. PubMed ID: 31005475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
